Perbedaan Indika Energy Tbk. dan Organon Pharma Indonesia Tbk.: Indika Energy Tbk. diperdagangkan di Rp2.830 (kapitalisasi pasar 15,01 T, volume 24 jam 27,38 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indika Energy Tbk. jauh lebih besar — sekitar 143,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INDY | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 15,01 T | 104,4 M |
Volume | 27,38 jt | — |
Lot | 273,78 rb | — |
Perputaran | 77,42 M | — |
Harga Rata-rata | 2.828,02 | — |
Nilai Transaksi | 77,42 M | — |
Harga Ekuilibrium Indikatif | 2.830 | — |
Volume Ekuilibrium Indikatif | 11,12 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
Indika Energy, PT (the company) was established under its original name of Dipta Diwangkara on Oct 19, 2000 then changed to PT Indika Energy based on Notaries Deed dated Aug 13, 2004.The Company’s articles of association has been amended several times, most recently by notarial deed No. 115 of Sutjipto, S.H., dated Feb 25, 2008, concerning among others, the change in par value, the Company’s name, and public offering.
Selengkapnya di halaman INDY →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →